Enveric Bioscience CEO Dr. Joseph Tucker joined Steve Darling from Proactive to share news about the company that is looking to help with the opioid crisis by using its technology to come up with a better to treat patients for anxiety, depression, and addiction. The company is using its development platform, The Psybrary, to come up with new Chemical Entities for specific mental health indications. Tucker tells Proactive more about the company and some of the key milestones the company has hit and some it is looking at hitting this year. He also talks about how the company’s approach and why he feels doing things different is the key to success.
Enveric Bioscience using novel small-molecule therapeutics for new way to treat multiple disorders
